Pharmaceuticals ICT Market Set to Surpass $79 Billion by 2028, Driven by Rising Budgets and Advanced Technology Adoption
November 21, 2024 04:17 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceuticals - Enterprise ICT" report has been added to ResearchAndMarkets.com's offering.The Pharmaceuticals Enterprise ICT report summarizes key...
Annual Pharma Supply Chain & Security World Summit 2025: Supply-Chain, Anti-Counterfeiting, Drug Serialization and Packaging & Labelling Conference (London, United Kingdom - March 11-12, 2025)
September 04, 2024 07:05 ET
|
Research and Markets
Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "Pharma Supply Chain & Security World 2025" conference has been added to ResearchAndMarkets.com's offering. The Annual Pharma Supply Chain &...
UK Patient's Perspective on the Corporate Reputation of Pharma, 2023-2024
August 20, 2024 11:52 ET
|
Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - UK Edition" report has been added to ResearchAndMarkets.com's offering. This...
Survey of 314 US Patient Groups Reveals Decline in Pharma Industry Reputation in 2023/2024
August 20, 2024 10:31 ET
|
Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups" report has been added to...
Corporate Reputation of Pharma in Canada, 2023/2024: The Views of 100 Canadian Patient Groups - Fair Pricing Policies, Transparency of Pricing, and Engaging Patients in R&D Among the Lowest-Scoring Indicators
June 26, 2024 09:25 ET
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups" report has been...
Survey Results of 830+ Patient Groups on the Pharmaceutical Industry and Environmental, Social, and Governance (ESG) Practices
June 24, 2024 11:44 ET
|
Research and Markets
Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World" report has been added to ...
Patient Perspective of 520 Cancer Patient Groups on the Corporate Reputation of Pharma in 2023/2024: Roche Ranked 1st, AstraZeneca Ranked 2nd, and Pfizer Ranked 3rd
June 21, 2024 08:54 ET
|
Research and Markets
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups" report has been...
Growth Opportunities and Business Models Driving Sustainability in Pharmaceuticals Industry with Focus on Case Studies for Johnson & Johnson, Astra Zeneca, Pfizer, Piramal Pharma Solutions, and Amcor
February 26, 2024 11:16 ET
|
Research and Markets
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities and Business Models Driving Sustainability in Pharmaceuticals Industry" report has been added to ResearchAndMarkets.com's...
AI in Pharma Sector Poised for Robust Growth: Opportunities & Strategies Report Uncovers Potential to 2032
January 29, 2024 11:36 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "AI in Pharma Global Market Opportunities and Strategies to 2032" report has been added to ResearchAndMarkets.com's offering. New research...
Global Botanical Drugs Market Size is Estimated to Reach USD 3,431.32 million in 2031, Growing at a CAGR of 39%: Straits Research
January 09, 2024 09:45 ET
|
Straits Research
New York, United States, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Botanical or natural drugs are products made and composed out of natural substances, which have constituents with health-improving or...